Morning Overview on MSN
The FDA approved an updated LP.8.1 COVID vaccine for adults 65 and older and high-risk people ages 5 through 64
Adults 65 and older, along with people ages 5 through 64 who face elevated risk from COVID-19, now have access to an updated ...
Add Yahoo as a preferred source to see more of our stories on Google. Older adults will continue to receive yearly COVID-19 shots, but lower-risk groups will not, says the FDA. dusanpetkovic via ...
As the nation gears up for the rollout of an updated COVID-19 vaccine, a new study shows the economic benefits of continued broad vaccination in adults. In fact, the country would ultimately save more ...
The death rate for COVID-19 in vaccinated older adults with low vitamin D was similar to unvaccinated older adults, but people with lower levels have a higher risk compared with people who had higher ...
It's been nearly a month since the U.S. government began urging older Americans to stay home to avoid exposure to the new coronavirus. That means many older adults may be running out of their usual 30 ...
Gen. Colin Powell, former secretary of state, died Monday at 84 from COVID-related complications, though he was fully ...
A new global study found that COVID-19 vaccines saved more than 2.5 million lives worldwide between 2020 and 2024 — and nearly 9 out of 10 of those lives were people aged 60 and older. The study, ...
INTRODUCED BEFORE CONGRESS. WELL, WITH FALL TRAVEL SEASON PICKING UP, HEALTH EXPERTS SAY IT’S ALSO THE RIGHT TIME TO ROLL UP YOUR SLEEVE. A NEWLY APPROVED COVID VACCINE IS NOW AVAILABLE FOR OLDER ...
As Covid-19 transmission ramps up in the United States, recent changes to federal vaccine guidance have left many Americans confused about the latest policies and concerned about access to shots this ...
The US Centers for Disease Control and Prevention strengthened recommendations for booster doses of coronavirus vaccine Monday, saying all adults should get boosted six months after the second dose of ...
Morning Overview on MSN
The FDA cleared Xocova, the first oral antiviral to prevent COVID-19 after exposure, in a five-day pill course shown to cut infections in a phase 3 trial
Households where someone tests positive for COVID-19 now have an oral drug option to protect the people around them. The FDA ...
With the common cold, flu, COVID-19 and RSV all presenting a threat of illness this fall and winter, here's how to distinguish between the symptoms of each condition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results